Zobrazeno 1 - 10
of 482
pro vyhledávání: '"David S, Pisetsky"'
Autor:
Kai Sun, Amanda M. Eudy, Nathaniel Harris, David S. Pisetsky, Lisa G. Criscione-Schreiber, Rebecca E. Sadun, Jayanth Doss, Megan E. B. Clowse, Jennifer L. Rogers
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 7, Iss 1, Pp 1-8 (2023)
Abstract Objective To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge discrepancies between patient- and physician-perceived SLE activity, we developed the Type 1 and 2 SLE model. We examined PROMIS-29 scores, a composite p
Externí odkaz:
https://doaj.org/article/62bf77c2e588407993cc3cbdfbb1f1c3
Autor:
David S Pisetsky, Rebecca E Sadun, Daniel Wojdyla, Kai Sun, Amanda M Eudy, Roberta Vezza Alexander, Lisa G Criscione-Schreiber, Mithu Maheswaranathan, Megan EB Clowse, Jennifer L Rogers, Jayanth Doss, Tyler O’Malley
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/7b6de56cd9bd4ed289aa6cbc46f3bab8
Autor:
David S Pisetsky, Rebecca E Sadun, Kai Sun, Amanda M Eudy, Megan E B Clowse, Lisa G Criscione-Schreiber, Mithu Maheswaranathan, Jennifer L Rogers, Jayanth Doss, Theresa Coles, Dana Burshell
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 2 (2023)
Objective Manifestations of SLE can be categorised as type 1 (classic signs and symptoms of SLE) or type 2 (fatigue, widespread pain and brain fog with an unclear relationship to inflammation). While measures of type 1 SLE activity exist, most curren
Externí odkaz:
https://doaj.org/article/bb9cc93da3ce41429f25c67777ec9ccd
Autor:
Daniel J. Wallace, Thomas Dörner, David S. Pisetsky, Jorge Sanchez‐Guerrero, Anand C. Patel, Dana Parsons‐Rich, Claire Le Bolay, Elise E. Drouin, Amy H. Kao, Hans Guehring, Maria Dall'Era
Publikováno v:
ACR Open Rheumatology, Vol 5, Iss 1, Pp 38-48 (2023)
Objective Evobrutinib is a highly selective, orally administered Bruton's tyrosine kinase (BTK) inhibitor. The objective of this phase II, multicenter, randomized, double‐blind, placebo‐controlled trial was to evaluate the efficacy and safety of
Externí odkaz:
https://doaj.org/article/fbfb7923863e4170999f2062f9b263dc
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2556 (2024)
Antibodies to DNA are a diverse set of antibodies that bind sites on DNA, a polymeric macromolecule that displays various conformations. In a previous study, we showed that sera of normal healthy subjects (NHS) contain IgG antibodies to Z-DNA, a left
Externí odkaz:
https://doaj.org/article/0196837542d44441a74f0769b0b835da
Autor:
David S Pisetsky, Rebecca E Sadun, Kai Sun, Amanda M Eudy, Lisa G Criscione-Schreiber, Mithu Maheswaranathan, Megan EB Clowse, Jennifer L Rogers, Jayanth Doss
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/233cc66cefd2406ab726a0f816b03b30
Autor:
David S Pisetsky, Peter E Lipsky, Amanda M Eudy, Megan EB Clowse, Jennifer L Rogers, Robert D Robl, Prathyusha S Bachali
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/a888574211e14eac8fca8ecae0d4baf5
Autor:
Lyra B. Olson, Nicole I. Hunter, Rachel E. Rempel, Haixiang Yu, Diane M. Spencer, Cynthia Z. Sullenger, William S. Greene, Anastasia K. Varanko, Seyed A. Eghtesadi, Ashutosh Chilkoti, David S. Pisetsky, Jeffrey I. Everitt, Bruce A. Sullenger
Publikováno v:
iScience, Vol 25, Iss 12, Pp 105542- (2022)
Summary: Nucleic acid-binding polymers can have anti-inflammatory properties and beneficial effects in animal models of infection, trauma, cancer, and autoimmunity. PAMAM G3, a polyamidoamine dendrimer, is fully cationic bearing 32 protonable surface
Externí odkaz:
https://doaj.org/article/c47c0949e0684823b161722dd21838e4
Autor:
David S Pisetsky, Rebecca E Sadun, Kai Sun, Amanda M Eudy, Megan E B Clowse, Lisa G Criscione-Schreiber, Mithu Maheswaranathan, Jennifer L Rogers, Jayanth Doss, Kevin McKenna, Amy Corneli
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Objective We have developed a new conceptual model to characterise the signs and symptoms of SLE: the Type 1 and 2 SLE Model. Within the original model, Type 1 SLE consists of inflammatory manifestations like arthritis, nephritis and rashes; Type 2 S
Externí odkaz:
https://doaj.org/article/a1e724684de7485cb8629de1af7f34bd
Autor:
David S Pisetsky, Daniel Wojdyla, Kai Sun, Amanda M Eudy, Lisa Criscione-Schreiber, Megan EB Clowse, Jennifer L Rogers, Jayanth Doss, Rebecca Sadun
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c9598291bbe245a0ba33fce5bedc36ea